Home / Pharmaceutical company intelligence
IRZA PHARMA (PVT) LTD logo
Pharmaceutical company intelligence

IRZA PHARMA (PVT) LTD

Private pharmaceutical manufacturer · Lahore · Pakistan

Long-established Lahore pharmaceutical manufacturer within the JAWA Group, producing multiple oral, liquid and injectable dosage forms.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date13 May 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
IRZA Pharma (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
10.2 KM, Lahore-Sheikhupura Road, Lahore, Pakistan
Phone
+92 42 37924842; +92 42 37924942
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
88%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000108 Irza Pharma (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000108 80 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx80public portfolio records represented
REG63unique registrations represented
IDX80indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR73current validated price records
G34generic molecules in indexed catalogue
DF7dosage-form groups
TA8therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage91%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage100%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixIRZA PHARMA (PVT) LTDShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/irza-pharma-pvt-ltdGenerated 23 Sep 2026Anti-infectives49 · 61%Pain & musculoskeletal8 · 10%Gastrointestinal & hepatology7 · 9%Vitamins, minerals & nutrition6 · 8%Cardiovascular5 · 6%Respiratory & allergy3 · 4%Endocrine & metabolic1 · 1%Other therapeutic areas1 · 1%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioIRZA PHARMA (PVT) LTDDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/irza-pharma-pvt-ltdGenerated 23 Sep 202680presentationsTablet39 · 49%Capsule20 · 25%Suspension13 · 16%Syrup3 · 4%Injection2 · 3%Solution2 · 3%Other forms1 · 1%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionIRZA PHARMA (PVT) LTDCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/irza-pharma-pvt-ltdGenerated 23 Sep 202680comparable productsBelow peer median57 · 71%Near peer median13 · 16%Above peer median10 · 13%Company median price position-18.6%Lowest-price equivalents7Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsIRZA PHARMA (PVT) LTDCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/irza-pharma-pvt-ltdGenerated 23 Sep 2026Mediate Pharmaceutical Pvt Ltd23 shared68% overlapMS SIZA INTERNATIONAL PVT LTD.23 shared68% overlapZafa Pharmaceutical Laboratories (P…22 shared65% overlapEpharm Laboratories21 shared62% overlapWerrick Pharmaceuticals20 shared59% overlapGlobal Pharmaceuticals (Pvt.) Ltd.19 shared56% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives49 products · 61%
Pain & musculoskeletal8 products · 10%
Gastrointestinal & hepatology7 products · 9%
Vitamins, minerals & nutrition6 products · 8%
Cardiovascular5 products · 6%
Respiratory & allergy3 products · 4%
Endocrine & metabolic1 products · 1%
Cross-therapeutic & anti-inflammatory1 products · 1%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Penicillin antibacterials10 products · 13%
Macrolide antibacterials8 products · 10%
Analgesics / NSAIDs8 products · 10%
Vitamins / minerals / hematinics6 products · 8%
Antimalarials6 products · 8%
Fluoroquinolone antibacterials4 products · 5%
Third-generation cephalosporins4 products · 5%
First-generation cephalosporins4 products · 5%
Formulation footprint

Dosage forms

Tablet39 products
Capsule20 products
Suspension13 products
Syrup3 products
Injection2 products
Solution2 products
Drops1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 JaxcilAmoxicillin 7presentations 250 mg, 250 mg/5 mL, 500 mg · Capsule, Suspension #2 JaefenIbuprofen 6presentations 100 mg/5 mL, 200 mg, 400 mg · Suspension, Tablet #3 I-ZitAzithromycin 4presentations 250 mg, 500 mg · Capsule, Tablet #4 LexinCephalexin 4presentations 125 mg/5 mL, 250 mg, 250 mg/5 mL, 500 mg · Suspension, Capsule #5 BiofolFolic acid 3presentations 5 mg · Tablet #6 Chloroquine PhosphateChloroquine 3presentations 250 mg · Tablet
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median5771% of comparable products
Near market median13within ±5% of median
Above market median1013% of comparable products
Lowest-price equivalents7ties included
Company median price position -18.6% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Biofol 5 mgFolic acid · Tablet · 1000's PKR 0.34/tablet-57.3% vs market median Jaxcil 125 mg + 31.25 mg/5 mLAmoxicillin + clavulanic acid · Suspension · 60ml PKR 1.45/mL-42.8% vs market median Irzacip 250 mgCiprofloxacin · Tablet · 10's PKR 15.48/tablet-39.1% vs market median Ivasc 10 mgAmlodipine · Tablet · 2x10's PKR 11.22/tablet-36.8% vs market median Ivasc 5 mgAmlodipine · Tablet · 2x10's PKR 6.97/tablet-35.8% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 23shared generics MS SIZA INTERNATIONAL PVT LTD.128 products · 63 generics 23shared generics Zafa Pharmaceutical Laboratories (Pvt) Ltd.245 products · 97 generics 22shared generics Epharm Laboratories144 products · 67 generics 21shared generics Werrick Pharmaceuticals249 products · 82 generics 20shared generics Global Pharmaceuticals (Pvt.) Ltd.224 products · 80 generics 19shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers63Distinct registrations among indexed, published, presentation-validated products only
Verified price observations80
Products with a verified price80
Products with multiple price observations0
Source records with multiple versions80
Latest portfolio source check22 Sep 2026
Latest effective price date13 May 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

63 unique registration(s) · 80 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Amoclave Amoxicillin + clavulanic acid 125 mg + 31.25 mg / 5 mL Dry suspension 60ml 069186 PKR 164.44 PKR 2.74/mL Near median
Biofol Folic acid 5 mg Tablet 5x20's 007803 PKR 74.29 PKR 0.74/tablet 8% below median
Biofol Folic acid 5 mg Tablet 100's 007803 PKR 65.55 PKR 0.66/tablet 19% below median
Biofol Folic acid 5 mg Tablet 1000's 007803 PKR 343.79 PKR 0.34/tablet 57% below median
Chloroquine Phosphate Chloroquine 250 mg Tablet 10x50's 002834 PKR 1,507.51 PKR 3.02/tablet 95% above median
Chloroquine Phosphate Chloroquine 250 mg Tablet 1000's 002834 PKR 2,895.84 PKR 2.90/tablet 88% above median
Chloroquine Phosphate Chloroquine 250 mg Tablet 10x10's 002834 PKR 301.28 PKR 3.01/tablet 95% above median
Glumetza Metformin 500 mg Tablet 5x10's 074498 PKR 114.50 PKR 2.29/tablet 16% below median
I-Cort Prednisolone 5 mg Tablet 1000's 060540 PKR 2,512.89 PKR 2.51/tablet 28% below median
I-Gent Eye/Ear Gentamicin 0.3 % Ear drops 7.5mlx1's 085209 PKR 35.18 PKR 4.69/mL 31% above median
I-Mide Metoclopramide 10 mg Injection 2mlx10's 087935 PKR 309.62 PKR 15.48/mL 21% below median
I-Sartan Losartan 25 mg Tablet 2x10's 060525 PKR 170.29 PKR 8.51/tablet 25% below median
I-Sartan Losartan 50 mg Tablet 2x10's 060526 PKR 309.62 PKR 15.48/tablet 25% below median
I-Sartan Plus Losartan + Hydrochlorothiazide 50 mg + 12.5 mg Tablet 2x10's 060541 PKR 464.43 PKR 23.22/tablet 25% below median
I-Tadin Loratadine 5 mg/5 mL Syrup 60ml 054451 PKR 75.86 PKR 1.26/mL 25% below median
I-Tadine Loratadine 10 mg Tablet 1x10's 054467 PKR 111.46 PKR 11.15/tablet 22% below median
I-Zit Azithromycin 250 mg Tablet 6's 054463 PKR 232.21 PKR 38.70/tablet 18% below median
I-Zit Azithromycin 250 mg Capsule 6's 054475 PKR 231.76 PKR 38.63/capsule 22% below median
I-Zit Azithromycin 250 mg Capsule 10's 054475 PKR 387.02 PKR 38.70/capsule 22% below median
I-Zit Azithromycin 500 mg Tablet 6's 078803 PKR 425.73 PKR 70.96/tablet 16% below median
Imide Metoclopramide 10 mg Tablet 10x10's 060524 PKR 167.53 PKR 1.68/tablet 26% below median
Irzacip Ciprofloxacin 250 mg Tablet 10's 057478 PKR 154.81 PKR 15.48/tablet 39% below median
Irzacip Ciprofloxacin 500 mg Tablet 10's 057479 PKR 309.62 PKR 30.96/tablet 28% below median
Irzaclare Clarithromycin 250 mg Tablet 10's 054462 PKR 371.54 PKR 37.15/tablet 22% below median
Irzaclare Clarithromycin 125 mg/5 mL Dry suspension 60ml 054469 PKR 345.22 PKR 5.75/mL 21% below median
Irzaclare Clarithromycin 500 mg Tablet 10's 057546 PKR 688.90 PKR 68.89/tablet 18% below median
Irzalac Lactulose 3.35 g/5 mL Syrup 120ml 057262 PKR 229.12 PKR 1.91/mL 21% below median
Irzazitho Azithromycin 200 mg/5 mL Suspension 15ml 054468 PKR 255.44 PKR 17.03/mL 22% below median
Irzazole Omeprazole 20 mg Capsule 14's 057261 PKR 222.93 PKR 15.92/capsule 19% below median
Irzazole Omeprazole 20 mg Capsule 10's 057261 PKR 159.45 PKR 15.95/capsule 19% below median
Ivasc Amlodipine 5 mg Tablet 2x10's 060527 PKR 139.33 PKR 6.97/tablet 36% below median
Ivasc Amlodipine 10 mg Tablet 2x10's 060528 PKR 224.47 PKR 11.22/tablet 37% below median
Jaefen Ibuprofen 200 mg Tablet 50x10's 012476 PKR 930.01 PKR 1.86/tablet 19% below median
Jaefen Ibuprofen 200 mg Tablet 500's 012476 PKR 930.01 PKR 1.86/tablet 19% below median
Jaefen Ibuprofen 100 mg/5 mL Suspension 90ml 012477 PKR 68.28 PKR 0.76/mL 20% below median
Jaefen Ibuprofen 100 mg/5 mL Suspension 450ml 012477 PKR 327.74 PKR 0.73/mL 23% below median
Jaefen Ibuprofen 400 mg Tablet 25x10's 012478 PKR 835.42 PKR 3.34/tablet Near median
Jaefen Ibuprofen 400 mg Tablet 250's 012478 PKR 835.42 PKR 3.34/tablet Near median
Jalacin Capsuels Clindamycin 300 mg Capsule 16;s 054471 PKR 425.73 PKR 26.61/capsule 26% below median
Jalacin Capsuels Clindamycin 150 mg Capsule 16's 054472 PKR 232.21 PKR 14.51/capsule 70% above median
Jantal Albendazole 200 mg Tablet 2's 067792 PKR 26.32 PKR 13.16/tablet 16% below median
Jawamycin Doxycycline 100 mg Capsule 10x10's 012479 PKR 856.10 PKR 8.56/capsule 9% above median
Jawamycin Doxycycline 100 mg Capsule 100's 012479 PKR 856.10 PKR 8.56/capsule 9% above median
Jawamycin Doxycycline 100 mg Tablet 5x10's 054457 PKR 309.62 PKR 6.19/tablet 22% below median
Jaxcil Amoxicillin 250 mg Capsule 20's 012480 PKR 215.20 PKR 10.76/capsule Near median
Jaxcil Amoxicillin 250 mg Capsule 100's 012480 PKR 1,076.01 PKR 10.76/capsule Near median
Jaxcil Amoxicillin 250 mg Capsule 12's 012480 PKR 129.12 PKR 10.76/capsule Near median
Jaxcil Amoxicillin 500 mg Capsule 20's 012481 PKR 388.47 PKR 19.42/capsule Near median
Jaxcil Amoxicillin 500 mg Capsule 100's 012481 PKR 1,901.50 PKR 19.02/capsule Near median
Jaxcil Amoxicillin 500 mg Capsule 12's 012481 PKR 233.08 PKR 19.42/capsule Near median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). IRZA PHARMA (PVT) LTD — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/irza-pharma-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.